Ads
related to: pharmaceutical drug companies- Find Answers to FAQs
Find Answers to Frequently Asked
Questions About SPRAVATO®
- Find a Treatment Center
Locate Your Nearest Certified
Treatment Center for SPRAVATO®
- Save on SPRAVATO®
Eligible patients pay $10/Tx
2024 Additional Requirements Apply
- How Treatment Works
Watch a Video to See the
SPRAVATO® Treatment Process
- What is Spravato®?
Get to Know SPRAVATO® and
How it Helps Adult Patients
- Watch Patient Stories
Watch Videos of Real Patients
With Real Stories
- Find Answers to FAQs
opvee.com has been visited by 10K+ users in the past month
Search results
Cencora data breach exposes US patient info from 8 drug companies
BleepingComputer· 5 days agoCencora, formerly AmerisourceBergen, is a pharmaceutical services provider specializing in drug...
Drug giant Takeda plans more than 640 layoffs in Massachusetts - The Boston Globe
The Boston Globe· 5 days agoTakeda Pharmaceutical, the largest drug maker in Massachusetts by headcount, on Friday confirmed...
Major drug companies caught up in Cencora data loss
The Register· 3 days agoMore than a dozen big pharmaceutical suppliers have begun notifying individuals that their data was stolen when US drug wholesaler Cencora was breached...
DEA clears MIRA-55 for further development By Investing.com
Investing.com· 6 hours agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), a pre-clinical stage pharmaceutical company, received a...
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 11 hours agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
Jazz Pharma share gets buy rating on FDA review news By Investing.com
Investing.com· 5 hours agoOn Wednesday, Jazz Pharmaceuticals (NASDAQ:JAZZ) received confirmation of a maintained Buy rating...
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
Digital Journal· 12 hours agoMilestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular ...
FDA prioritizes review of Jazz Pharmaceuticals' new cancer therapy By Investing.com
Investing.com· 6 hours agoJazz Pharmaceuticals (NASDAQ:JAZZ) announced that the U.S. Food and Drug Administration (FDA) has...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 hours agoData on an obesity drug in development is encouraging, but it needs to be differentiated from other treatments on the market, Berenberg says. Likewise,...
Drug companies pay doctors over A$11 million a year for travel and education - EconoTimes
EconoTimes· 6 days agoDrug companies are paying Australian doctors millions of dollars a year to fly to overseas...